Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
BIOTECHNOLOGY: Singapore Firm Abandons Plans for Stem Cell Therapies
Dennis Normile
In a sign that hopes for quick medical benefits from stem cells are fading, ES Cell International--a company established with fanfare in Singapore 7 years ago--is halting work on human embryonic stem cell therapies.